Hideki Garren

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

Christopher Lock, G Hermans, Rosetta Pedotti et al. · Nature Medicine · 2002 · 1.7K citations

Neurogenomics, Immunology, Pathology +17

The drosophila sine oculis locus encodes a homeodomain-containing protein required for the development of the entire visual system

Benjamin Cheyette, Patricia J. Green, K. Martin et al. · Neuron · 1994 · 513 citations

Biology, Developmental Biology, Developmental Genetics +10

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Anthony Traboulsee, Benjamin Greenberg, Jeffrey L. Bennett et al. · The Lancet Neurology · 2020 · 456 citations · Full text

Satralizumab Monotherapy, Placebo-controlled Phase 3, Ophthalmology +4